These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 6831399

  • 1. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC, Schurig JE, Huftalen JB, Bradner WT.
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract] [Full Text] [Related]

  • 2. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF, Muggia FM, Johnson RK.
    Cancer Treat Rep; 1979 Apr; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract] [Full Text] [Related]

  • 3. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R, Bourat G, Ducrot R, Fournel J, Ganter P, Julou L, Koenig F, Myon J, Pascal S, Pasquet J, Populaire P, de Ratuld Y, Werner GH.
    Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
    [No Abstract] [Full Text] [Related]

  • 4. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Schlein A, Huftalen JB.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [Abstract] [Full Text] [Related]

  • 5. Experimental evaluation of anthracycline analogs.
    Casazza AM.
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [Abstract] [Full Text] [Related]

  • 6. [Animal experimental examination of a phase III study on the effect of the combination therapy of bruneomycin, cytostasan and prednisone].
    Nowak C, Arnold W, Henneberger G, Tanneberger S.
    Arch Geschwulstforsch; 1983 May; 53(1):37-44. PubMed ID: 6344835
    [Abstract] [Full Text] [Related]

  • 7. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 8. [Antitumor activity of macromomycin].
    Kato T, Yamanaka N, Katayama S, Mizutani M, Ota K.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP, van't Riet B, Wampler GL.
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antitumour activity of some cyclophosphazenes.
    Labarre JF, Faucher JP, Levy G, Sournies F, Cros S, François G.
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract] [Full Text] [Related]

  • 14. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP.
    Cancer Treat Rep; 1980 May; 64(4-5):727-9. PubMed ID: 6448690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
    Mayer LD, Bally MB, Loughrey H, Masin D, Cullis PR.
    Cancer Res; 1990 Feb 01; 50(3):575-9. PubMed ID: 2297698
    [Abstract] [Full Text] [Related]

  • 17. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
    Demidova NS, Goncharova SA, Shiriaeva OA, Konovalova NP.
    Eksp Onkol; 1989 Feb 01; 11(1):65-8. PubMed ID: 2924713
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS, Schmid FA, Hutchison DJ, Stock CC.
    Cancer Chemother Rep; 1973 Feb 01; 57(1):21-7. PubMed ID: 4704098
    [No Abstract] [Full Text] [Related]

  • 19. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
    Catsoulacos P, Camoutsis C, Wampler GL.
    Oncology; 1982 Feb 01; 39(1):59-60. PubMed ID: 7058047
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of kijanimicin.
    Bradner WT, Claridge CA, Huftalen JB.
    J Antibiot (Tokyo); 1983 Aug 01; 36(8):1078-9. PubMed ID: 6630059
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.